Hims & Hers GLP-1 Super Bowl Ad Sparks Debate On FDA Compliance

By Maaisha Osman / February 7, 2025 at 3:22 PM

Telehealth company Hims & Hers Health is set to air its first Super Bowl ad Sunday (Feb. 9), promoting compounded weight-loss drugs -- sparking allegations from a bipartisan Senate duo, the Pharmaceutical Research and Manufacturers of America (PhRMA) and a public health group that the ad is misleading and goes against the intent of FDA’s prescription drug advertising rules.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.